Coffee for Neuroprotection

Research suggests that coffee consumption may offer neuroprotective benefits relevant to a range of conditions including Alzheimer's disease, Parkinson's disease, multiple sclerosis, ALS, and general cognitive aging, with the available evidence drawn primarily from laboratory studies, animal models, epidemiological data, and narrative and systematic reviews rather than large-scale randomized controlled trials. Studies indicate that these potential effects are likely not attributable to caffeine alone, but rather to a combination of bioactive compounds — including chlorogenic acid, trigonelline, cafestol, and eicosanoyl-5-hydroxytryptamide — that may act through multiple mechanisms such as reducing oxidative stress and neuroinflammation, activating cellular defense pathways like NRF2 and Nrf2, modulating adenosine receptors, and supporting healthy protein clearance in the brain. One longitudinal observational study introduced a note of caution, finding that high coffee intake was associated with faster cognitive decline compared to moderate intake in older adults, and a review of coffee's hormonal activity highlighted inconsistent and sometimes contradictory biological effects among its chemical constituents. Overall, the body of evidence is promising but largely preclinical and observational, and researchers consistently emphasize that well-designed human clinical trials are still needed to confirm which specific compounds are responsible, at what levels of intake benefits may occur, and whether these associations reflect genuine causal neuroprotection.